1. Positron Emission Tomography-Computed Tomography Parameters Predict Efficacy of Immunotherapy in Head and Neck Squamous Cell Carcinomas
    Songtao Zhang et al, 2021, Frontiers in Oncology CrossRef
  2. Absolute lymphocyte count is an independent predictor of survival in patients with metastatic renal cell carcinoma treated with nivolumab
    Kosuke Ueda et al, 2022, Japanese Journal of Clinical Oncology CrossRef
  3. Small molecule tyrosine kinase inhibitors modulated blood immune cell counts in patients with oncogene-driven NSCLC
    Weijie Ma et al, 2021, Biomarker Research CrossRef
  4. Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio during immune checkpoint inhibitor treatment in recurrent or metastatic head and neck squamous cell carcinoma patients
    Jun-Liang Li et al, 2022, Oral Oncology CrossRef
  5. Modeling of radiation effects to immune system: a review
    Wonmo Sung et al, 2022, Journal of the Korean Physical Society CrossRef
  6. Current and Future Biomarkers for Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma
    Jong Chul Park et al, 2022, Current Oncology CrossRef
  7. Impact of lymphopenia on efficacy of nivolumab in head and neck cancer patients
    Mathieu Césaire et al, 2023, European Archives of Oto-Rhino-Laryngology CrossRef
  8. A systematic review and meta-analysis of prognostic indicators in patients with head and neck malignancy treated with immune checkpoint inhibitors
    Dengxiong Kang et al, 2023, Journal of Cancer Research and Clinical Oncology CrossRef
  9. Immune‐modified Glasgow prognostic score: A new prognostic marker for head and neck cancer
    Kosuke Terazawa et al, 2022, Head & Neck CrossRef
  10. Patterns of recurrence in head and neck squamous cell carcinoma to inform personalized surveillance protocols
    Catherine T. Haring et al, 2023, Cancer CrossRef
  11. Neutrophil‐to‐lymphocyte ratio as a prognostic marker for head and neck squamous cell carcinoma treated with immune checkpoint inhibitors: Meta‐analysis
    Yukinori Takenaka et al, 2022, Head & Neck CrossRef
  12. Pretreatment total lymphocyte count as a prognostic factor of survival in patients with recurrent cervical cancer after definitive radiation-based therapy: a retrospective study
    Ekasak Thiangphak et al, 2023, Obstetrics & Gynecology Science CrossRef
  13. Emerging precision neoadjuvant systemic therapy for patients with resectable non-small cell lung cancer: current status and perspectives
    Luis A. Godoy et al, 2023, Biomarker Research CrossRef